GGrantIndex
Sort

53,477 grants matching addiction

Delineating genetic risk to addiction via analysis of 3D chromatin architecture

$555,750
Olivia Gabrielle Corradin · Whitehead Institute For Biomedical Res · DP1 · FY2017 · DA

Delineating genetic risk to addiction via analysis of 3D chromatin architecture

$555,750
Olivia Gabrielle Corradin · Whitehead Institute For Biomedical Res · DP1 · FY2021 · DA

Delineating genetic risk to addiction via analysis of 3D chromatin architecture

$555,750
Olivia Gabrielle Corradin · Whitehead Institute For Biomedical Res · DP1 · FY2018 · DA

Delineating genetic risk to addiction via analysis of 3D chromatin architecture

$555,750
Olivia Gabrielle Corradin · Whitehead Institute For Biomedical Res · DP1 · FY2019 · DA

Multimedia Addiction Severity Index for Adolescents

$555,745
Inflexxion, Inc. · R44 · FY2003 · DA

Appalachian Tri-State Node

$555,727
Dennis C Daley · University Of Pittsburgh At Pittsburgh · U10 · FY2013 · DA

Development of the Opioid Use Disorder Severity Scale

$555,610
Brian D. Kiluk · Yale University · U01 · FY2022 · DA

Memantine Naltrexone Treatment for Opioid Dependence

$555,581
Adam Mariusz Bisaga · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2009 · DA

INTERVENTION TO REDUCE INJECTION DRUG USE

$555,475
University Of Colorado Denver · R01 · FY2001 · DA

Physiology and Pharmacology of Brain Reward Circuits

$555,467
Carl R. Lupica · National Institute On Drug Abuse · ZIA · FY2015 · DA

Long Term THC Elicits Distinct Changes in Adolescent Brain Dopamine Signaling

$555,359
Bertha K Madras · Mclean Hospital · R01 · FY2021 · DA

Serotonin modulation of the development of neural circuits underlying reward processing and impulsivity in adolescents

$555,302
Katherine M Nautiyal · Dartmouth College · R01 · FY2023 · MH

Gender Differences in a Follow-up of Opiate Users in Ca

$555,290
University Of California Los Angeles · R01 · FY2005 · DA

Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial

$555,250
Philip Todd Korthuis · Oregon Health & Science University · R01 · FY2017 · DA

Time Horizons and the Behavioral Economics of Recovery from Drinking Problems

$554,964
Jalie A Tucker · University Of Alabama At Birmingham · R01 · FY2012 · AA

Maternal Lifestyle Study Phase 5

$554,943
Henrietta S. Bada · University Of Tennessee Health Sci Ctr · U10 · FY2009 · DA

Project HOPE - Exploring the Role of Harm Reduction Vending Machines in Reducing the Risk of HIV Infection and Transmission

$554,922
Ashleigh Nicole Scinta Herrera · California State University Bakersfield Auxiliary For Sponsored Programs Administration · R15 · FY2025 · DA

Amygdala kappa opioid system involvement in opioid relapse in pain states

$554,896
Catherine M Cahill · University Of California Los Angeles · R01 · FY2025 · DA

Amygdala kappa opioid system involvement in opioid relapse in pain states

$554,896
Catherine M Cahill · University Of California Los Angeles · R01 · FY2024 · DA

A therapeutic workplace for homeless adults with alcohol use disorders

$554,887
Kenneth Silverman · Johns Hopkins University · R01 · FY2019 · AA

Targeting Hedonic Dysregulation to Address Chronic Pain and Opioid Misuse in Primary Care.

$554,878
Eric Lee Garland · University Of Utah · R01 · FY2019 · DA

Family Therapy via Video Teleconference for Substance-Abusing Rural Adolescents

$554,866
Timothy J Ozechowski · Oregon Research Institute · R01 · FY2015 · DA

Using the Genetic Architecture of Substance Use Disorders to Advance Gene Identification and Understanding of Pathways of Risk

$554,862
Danielle M Dick · Virginia Commonwealth University · R01 · FY2021 · DA

Neuropsychobiology in Polysubstance Abusers during Abstinence

$554,849
Dieter J Meyerhoff · Northern California Institute/Res/Edu · R01 · FY2016 · DA

Circadian and sleep mechanisms among racial groups for nicotine dependence, craving, and withdrawal

$554,708
Karen L Cropsey · University Of Alabama At Birmingham · R01 · FY2023 · DA